This issue of Hematology/Oncology Clinics, Guest Edited by Dr. Guru P. Sonpavde, is devoted to Bladder Cancer. This issue is one of six selected each year by our series Consulting Editors, George P. Canellos and Edward J. Benz. Topics discussed in this important issue include: Epidemiology of bladder cancer, The molecular biology of bladder cancer and potential implications for therapy, Current therapy for metastatic urothelial carcinoma, Current perioperative therapy for muscle invasive urothelial carcinoma, Current therapy and emerging intravesical agents to treat non-muscle invasive bladder cancer, Diagnosis and staging of bladder and upper tract urothelial cancer, Surgery for bladder and upper tract urothelial cancer, Bladder conserving therapy for muscle invasive bladder cancer: opportunities to incorporate molecular profiling, Emerging immunotherapy for bladder cancer, Emerging targeted therapy for bladder cancer, Real world outcomes of patients with bladder cancer, Preclinical systems to develop bladder cancer therapeutics, Developing precision medicine for bladder cancer, and Future Directions in Bladder Cancer Treatment and Research.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. The Epidemiology of Bladder Cancer - p. 445 9. Molecular Biology of Bladder Cancer: Potential Implications for Therapy - p. 457 10. Current Therapy for Metastatic Urothelial Carcinoma - p. 469 11. Current Perioperative Therapy for Muscle Invasive Bladder Cancer - p. 495 12. Current Therapy and Emerging Intravesical Agents to Treat Non–Muscle Invasive Bladder Cancer - p. 513 13. Diagnosis and Staging of Bladder Cancer - p. 531 14. Surgery for Bladder and Upper Tract Urothelial Cancer - p. 543 15. Contemporary and Emerging Approaches to Bladder-Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer - p. 567 16. Emerging Targeted Therapy for Bladder Cancer - p. 585 17. Real World Outcomes of Patients with Bladder Cancer: Effectiveness Versus Efficacy of Modern Treatment Paradigms - p. 597 18. Preclinical Models for Bladder Cancer Research - p. 613 19. Developing Precision Medicine for Bladder Cancer - p. 633 20. Future Directions in Bladder Cancer Treatment and Research—The Patient Advocates’ Perspective - p. 655
This issue of Hematology/Oncology Clinics, Guest Edited by Dr. Guru P. Sonpavde, is devoted to Bladder Cancer. This issue is one of six selected each year by our series Consulting Editors, George P. Canellos and Edward J. Benz. Topics discussed in this important issue include: Epidemiology of bladder cancer, The molecular biology of bladder cancer and potential implications for therapy, Current therapy for metastatic urothelial carcinoma, Current perioperative therapy for muscle invasive urothelial carcinoma, Current therapy and emerging intravesical agents to treat non-muscle invasive bladder cancer, Diagnosis and staging of bladder and upper tract urothelial cancer, Surgery for bladder and upper tract urothelial cancer, Bladder conserving therapy for muscle invasive bladder cancer: opportunities to incorporate molecular profiling, Emerging immunotherapy for bladder cancer, Emerging targeted therapy for bladder cancer, Real world outcomes of patients with bladder cancer, Preclinical systems to develop bladder cancer therapeutics, Developing precision medicine for bladder cancer, and Future Directions in Bladder Cancer Treatment and Research.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. The Epidemiology of Bladder Cancer - p. 445 9. Molecular Biology of Bladder Cancer: Potential Implications for Therapy - p. 457 10. Current Therapy for Metastatic Urothelial Carcinoma - p. 469 11. Current Perioperative Therapy for Muscle Invasive Bladder Cancer - p. 495 12. Current Therapy and Emerging Intravesical Agents to Treat Non–Muscle Invasive Bladder Cancer - p. 513 13. Diagnosis and Staging of Bladder Cancer - p. 531 14. Surgery for Bladder and Upper Tract Urothelial Cancer - p. 543 15. Contemporary and Emerging Approaches to Bladder-Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer - p. 567 16. Emerging Targeted Therapy for Bladder Cancer - p. 585 17. Real World Outcomes of Patients with Bladder Cancer: Effectiveness Versus Efficacy of Modern Treatment Paradigms - p. 597 18. Preclinical Models for Bladder Cancer Research - p. 613 19. Developing Precision Medicine for Bladder Cancer - p. 633 20. Future Directions in Bladder Cancer Treatment and Research—The Patient Advocates’ Perspective - p. 655
